Research News

An international team of scientists will today receive the prestigious 2018 Helen Keller Prize for Vision Research. The prize, presented by BrightFocus Foundation, honors scientific excellence and is chosen by an awards committee of the Helen Keller Foundation for Research and Education.

BrightFocus Foundation recognizes six scientists studying macular degeneration and glaucoma, awarding research grants named in honor of leaders in vision science.

A BrightFocus grantee is adapting MRI and other imaging tests to create a multimodal approach to diagnosing early Alzheimer’s. Earlier diagnosis could mean earlier treatment and cure.

BrightFocus Foundation, a nonprofit and premier source of research funding to defeat Alzheimer’s, macular degeneration, and glaucoma, today was acknowledged as the catalyst behind a major advance in drug development for Alzheimer’s disease.

Ruchira Singh and colleagues at the University of Rochester and worldwide have shown that even rare forms of macular degeneration develop in ways similar to AMD, with drusen formation and extracellular proteins. The goal ahead: effective early treatment approaches.